Drug profile · INN
carteolol hydrochloride
CARTEOLOL HYDROCHLORIDE
carteolol hydrochloride (CARTEOLOL HYDROCHLORIDE) is a adrenergic receptor beta antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — carteolol hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
carteolol hydrochloride (CARTEOLOL HYDROCHLORIDE) is a adrenergic receptor beta antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor beta antagonist
Primary target: Adrenergic receptor beta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is carteolol hydrochloride?
carteolol hydrochloride (CARTEOLOL HYDROCHLORIDE) is a adrenergic receptor beta antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for carteolol hydrochloride?
CARTEOLOL HYDROCHLORIDE is a marketed brand name for carteolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carteolol hydrochloride?
carteolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.